Aller au contenu

514 606-3350

info@cliniqueomicron.ca​

FR / EN
Logo - Clinique Omicron
Make an appointment
Laboratory medicine : Hepatology and liver function

Complete liver workup

Conduct this analysis

Blood draws at our service locations in Quebec. A healthcare professional can also review your results with you.

A comprehensive liver panel is a set of blood tests used to assess the functional and structural status of the liver, the bile ducts and, in part, the adjacent pancreas. It includes several markers with distinct biological meanings: transaminases (ALT and AST), which reflect the integrity of hepatocytes; alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT), indicators of biliary involvement or enzyme induction; total bilirubin and its fractions, which provide information on pigment metabolism and excretory function; as well as albumin and prothrombin time (PT), which reflect the liver's synthetic capacity. This panel is the first-line tool for screening, diagnosing and monitoring acute or chronic liver diseases, whether of viral, drug-induced, alcoholic, metabolic or autoimmune origin. It is frequently ordered in preventive medicine, during periodic health check-ups, in a surgical context or when starting potentially hepatotoxic treatments.
Warning signs requiring urgent consultation

Rapid-onset jaundice, severe abdominal pain in the right upper quadrant, confusion or altered consciousness associated with known liver disease, or signs of upper gastrointestinal bleeding (vomiting blood, black stools) are situations that may indicate acute liver failure or a serious complication requiring immediate medical evaluation.

Call 911 immediately

Panel components and reference values

Reference values may vary depending on the laboratory, sex and age. The ranges shown below correspond to the adult standards most commonly used in Quebec.

Marker Abbreviation Usual values Origine principale
Alanine aminotransferase ALAT (ALT) 7 to 56 U/L Hepatocyte cytoplasm; specific marker of hepatocellular injury
Aspartate aminotransferase ASAT (AST) 10 to 40 U/L Hepatocytes, cardiac and skeletal muscle, kidney; less specific to the liver than ALT
Phosphatase alcaline PAL (ALP) 44 to 147 U/L Biliary epithelium, bone, intestine, placenta; marker of cholestasis or bone involvement
Gamma-glutamyl transferase GGT Men: 8 to 61 U/L; Women: 5 to 36 U/L Hepatocytes and biliary epithelium; very sensitive to alcohol and enzyme inducers
Total bilirubin Bili T 3 to 21 µmol/L Breakdown product of hemoglobin; transported to the liver for conjugation and biliary excretion
Conjugated (direct) bilirubin Bili C Less than 5 µmol/L Water-soluble fraction, excreted in bile; elevated in biliary obstruction or hepatitis
Unconjugated (indirect) bilirubin Bili NC Less than 17 µmol/L Albumin-bound fraction; elevated in hemolysis or Gilbert's syndrome
Serum albumin Alb 35 to 50 g/L Synthesized exclusively by the liver; marker of long-term hepatic synthetic function
Prothrombin time TP (RNI) PT: 70 to 100%; INR: 0.8 to 1.2 Reflects the synthesis of vitamin K-dependent clotting factors; falls rapidly in acute hepatocellular failure
Lactate dehydrogenase LDH 135 to 225 U/L Ubiquitous enzyme; not very specific, but useful in certain contexts (hemolysis, massive hepatic necrosis)
ℹ️ GGT is a very sensitive but not very specific marker. It rises in response to alcohol, many medications (antiepileptics, statins, antifungals), obesity and certain thyroid diseases, independently of any significant structural liver damage.

Laboratory patterns and their interpretation

Liver panel analysis relies on recognizing patterns of combined abnormalities, each pointing to a distinct diagnostic category.

Profile Anomalies dominantes Common causes
Hepatocellular injury Elevated ALT and AST, ALT predominant Viral hepatitis (A, B, C, E), drug-induced or toxic hepatitis, non-alcoholic steatohepatitis (NASH), alcoholic hepatitis, autoimmune hepatitis
Hepatocellular injury with AST predominance AST/ALT ratio greater than 2 Alcoholic hepatitis (De Ritis ratio), concomitant muscle involvement (rhabdomyolysis, myocardial infarction)
Cholestasis Elevated ALP and GGT, elevated conjugated bilirubin Gallstones, cholangitis, primary biliary cirrhosis, drug-induced cholestasis, neoplasm of the bile ducts or pancreas
Jaundice with unconjugated bilirubin Elevated indirect bilirubin, normal transaminases Gilbert's syndrome (benign), hemolysis, Crigler-Najjar syndrome
Hepatocellular failure Low albumin, low PT, elevated bilirubin Advanced cirrhosis, acute liver failure, fulminant hepatitis
Isolated enzyme induction Elevated GGT, other markers normal Alcohol consumption, enzyme-inducing medications, obesity, type 2 diabetes

Main causes of liver abnormalities

Category Examples
Virales Hepatitis A, B, C, D, E; Epstein-Barr virus (mononucleosis); cytomegalovirus
Drug-induced and toxic Acetaminophen (paracetamol) overdose, statins, anti-tuberculosis drugs, azole antifungals, NSAIDs, herbal medicine and unregulated supplements
Metabolic Non-alcoholic fatty liver disease (NAFLD/MASLD), type 2 diabetes, obesity, dyslipidemia, metabolic syndrome
Alcooliques Alcoholic steatosis, alcoholic hepatitis, alcoholic cirrhosis
Auto-immunes Autoimmune hepatitis, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC)
Genetic and metabolic Hereditary hemochromatosis, Wilson's disease, alpha-1 antitrypsin deficiency
Vasculaires Budd-Chiari syndrome, hepatic congestion in right-sided heart failure
Neoplastic Hepatocellular carcinoma, liver metastases, cholangiocarcinoma
Obstructives Common bile duct stones, biliary stricture, pancreatic cancer, extrinsic compression

Diagnostic approach to an abnormal liver panel

An isolated or combined elevation of liver markers calls for a structured approach aimed at identifying the etiology before guiding management.

  • Complete medical history: alcohol consumption, medications (including natural products), family history, risk factors for chronic diseases
  • Characterizing the pattern: cytolysis, cholestasis, hepatocellular insufficiency or mixed pattern
  • Viral serology: anti-HAV antibodies, HBsAg, anti-HBc, anti-HCV depending on the context
  • Liver autoimmune panel: ANA, ASMA, anti-LKM1, anti-mitochondrial antibodies (AMA)
  • Metabolic workup: fasting blood glucose, HbA1c, lipid panel, BMI
  • Overload workup: ferritin, transferrin saturation (hemochromatosis); ceruloplasmin, serum copper (Wilson)
  • Abdominal ultrasound: morphological assessment of the liver, bile ducts and gallbladder
  • Liver elastography (Fibroscan) or non-invasive fibrosis score (FIB-4, APRI) if chronic fibrosis is suspected
  • Referral to gastroenterology or hepatology if the abnormality is persistent, severe or of undetermined etiology
ℹ️ A transient, moderate rise in transaminases (less than three times the normal value) after intense physical exertion, recent medication use or a mild viral infection does not necessarily indicate liver disease. A repeat blood test at a later time, under baseline conditions, often makes it possible to confirm or rule out whether the abnormality persists before undertaking further investigations.

Situations requiring regular liver function monitoring

  • Treatment with statins, anti-tuberculosis drugs, methotrexate, amiodarone or other medications with recognized hepatotoxic potential
  • Chronic alcohol use or history of alcohol-related liver disease
  • Chronic hepatitis B or C under antiviral treatment or follow-up
  • Metabolic syndrome, obesity or type 2 diabetes with suspected NAFLD/MASLD
  • Known liver cirrhosis, at any stage
  • Family history of hemochromatosis, Wilson disease or hepatocellular carcinoma
  • Preoperative assessment for major abdominal or hepatobiliary surgery

Consult at Clinique Omicron

A complete liver panel can be ordered and interpreted by Clinique Omicron physicians and nurse practitioners (IPS) as part of preventive medicine follow-up, an annual health check-up or a targeted investigation. Results are analyzed in light of the patient's overall clinical context in order to guide further investigations or referral to the appropriate specialty as needed. Book an appointment online or by phone at one of Clinique Omicron's points of service in Quebec.

The content of this page is provided for informational purposes only and is not intended to replace the advice of a qualified healthcare professional. Consult a physician for any symptoms, questions or decisions you may have regarding your health.

Omicron Clinic

Need to consult a doctor?

In-person or via telemedicine, anywhere in Quebec.

We accept insurance. Telemedicine consultations available 7 days a week. No family doctor required.